Zhongshan Hengsai Biotechnology Co.
Latest round
- Series A
Last raised
- Nov 2023
Total raised
- Undisclosed
Investors
- 3
About Zhongshan Hengsai Biotechnology Co.
, Ltd. is a medical company that focuses on the research and development of tumor therapy vaccines. It was recognized as the National High-Tech Enterprise. Huining Liu, the founder and CEO of the company, graduated from Harvard Medical School and used to work for BMS and Quintiles. The company's R&D center and plant in Shanghai came into operation in 2021., Ltd. The company is committed to developing individualized dendritic cell tumor therapeutic vaccines (DC vaccine). It constructed the Eco-DCVax platform for the development of DC vaccine products. Products within include therapeutic dendritic cell vaccine, which can be used in the treatment of lymphoma, chronic viral infections, autoimmune diseases, and chronic active EB virus infection. The company generates revenue from providing biotechnology services.
Who invested in Zhongshan Hengsai Biotechnology Co.
3 investors across 1 round
See all investors in Zhongshan Hengsai Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 27, 2023
Amount
Undisclosed
Investors
Questions about Zhongshan Hengsai Biotechnology Co.
Who invested in Zhongshan Hengsai Biotechnology Co.?
Zhongshan Hengsai Biotechnology Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zhongshan Hengsai Biotechnology Co. raised?
Zhongshan Hengsai Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Zhongshan Hengsai Biotechnology Co. last raise money?
Zhongshan Hengsai Biotechnology Co.'s most recent round on record is a Series A, in Nov 2023.
What does Zhongshan Hengsai Biotechnology Co. do?
Zhongshan Hengsai Biotechnology Co. is a biotechnology company.
Where is Zhongshan Hengsai Biotechnology Co. headquartered?
Zhongshan Hengsai Biotechnology Co. is headquartered in Zhongshan, China.
Which VCs invest in companies like Zhongshan Hengsai Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Zhongshan Hengsai Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Zhongshan Hengsai Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.